9-95516690-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_001083603.3(PTCH1):​c.131A>G​(p.Glu44Gly) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00157 in 1,612,088 control chromosomes in the GnomAD database, including 30 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/16 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0068 ( 13 hom., cov: 32)
Exomes 𝑓: 0.0010 ( 17 hom. )

Consequence

PTCH1
NM_001083603.3 missense

Scores

14

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:8O:1

Conservation

PhyloP100: -1.81

Publications

17 publications found
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]
PTCH1 Gene-Disease associations (from GenCC):
  • basal cell nevus syndrome 1
    Inheritance: AD Classification: DEFINITIVE Submitted by: G2P
  • holoprosencephaly 7
    Inheritance: AD Classification: DEFINITIVE, LIMITED Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P
  • nevoid basal cell carcinoma syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae), Orphanet
  • holoprosencephaly
    Inheritance: AD Classification: LIMITED Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.002708137).
BP6
Variant 9-95516690-T-C is Benign according to our data. Variant chr9-95516690-T-C is described in ClinVar as Likely_benign. ClinVar VariationId is 41768.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population afr. GnomAd4 allele frequency = 0.00684 (1037/151610) while in subpopulation AFR AF = 0.0218 (899/41310). AF 95% confidence interval is 0.0206. There are 13 homozygotes in GnomAd4. There are 521 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 1037 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001083603.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
NM_001083603.3
MANE Plus Clinical
c.131A>Gp.Glu44Gly
missense
Exon 1 of 24NP_001077072.1
PTCH1
NM_001083602.3
c.-219A>G
5_prime_UTR
Exon 1 of 24NP_001077071.1
PTCH1
NM_001354919.2
c.-219A>G
5_prime_UTR
Exon 1 of 5NP_001341848.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PTCH1
ENST00000437951.6
TSL:5 MANE Plus Clinical
c.131A>Gp.Glu44Gly
missense
Exon 1 of 24ENSP00000389744.2
PTCH1
ENST00000468211.6
TSL:1
c.-219A>G
5_prime_UTR
Exon 1 of 5ENSP00000449745.1
PTCH1
ENST00000430669.6
TSL:5
c.-219A>G
5_prime_UTR
Exon 1 of 23ENSP00000410287.2

Frequencies

GnomAD3 genomes
AF:
0.00686
AC:
1039
AN:
151490
Hom.:
13
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0219
Gnomad AMI
AF:
0.00773
Gnomad AMR
AF:
0.00151
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.0159
Gnomad SAS
AF:
0.000416
Gnomad FIN
AF:
0.0000948
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000177
Gnomad OTH
AF:
0.00625
GnomAD2 exomes
AF:
0.00281
AC:
694
AN:
246616
AF XY:
0.00254
show subpopulations
Gnomad AFR exome
AF:
0.0218
Gnomad AMR exome
AF:
0.00156
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.0151
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000107
Gnomad OTH exome
AF:
0.00250
GnomAD4 exome
AF:
0.00102
AC:
1489
AN:
1460478
Hom.:
17
Cov.:
31
AF XY:
0.000932
AC XY:
677
AN XY:
726592
show subpopulations
African (AFR)
AF:
0.0216
AC:
720
AN:
33322
American (AMR)
AF:
0.00180
AC:
80
AN:
44478
Ashkenazi Jewish (ASJ)
AF:
0.0000766
AC:
2
AN:
26120
East Asian (EAS)
AF:
0.00921
AC:
365
AN:
39642
South Asian (SAS)
AF:
0.000465
AC:
40
AN:
86048
European-Finnish (FIN)
AF:
0.0000375
AC:
2
AN:
53386
Middle Eastern (MID)
AF:
0.000694
AC:
4
AN:
5762
European-Non Finnish (NFE)
AF:
0.000111
AC:
123
AN:
1111408
Other (OTH)
AF:
0.00254
AC:
153
AN:
60312
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
81
161
242
322
403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
36
72
108
144
180
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00684
AC:
1037
AN:
151610
Hom.:
13
Cov.:
32
AF XY:
0.00703
AC XY:
521
AN XY:
74108
show subpopulations
African (AFR)
AF:
0.0218
AC:
899
AN:
41310
American (AMR)
AF:
0.00151
AC:
23
AN:
15244
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3468
East Asian (EAS)
AF:
0.0158
AC:
80
AN:
5074
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4804
European-Finnish (FIN)
AF:
0.0000948
AC:
1
AN:
10554
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000177
AC:
12
AN:
67856
Other (OTH)
AF:
0.00666
AC:
14
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
47
95
142
190
237
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00236
Hom.:
5
Bravo
AF:
0.00773
ESP6500AA
AF:
0.0154
AC:
57
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.00305
AC:
369
Asia WGS
AF:
0.00664
AC:
23
AN:
3478
EpiCase
AF:
0.0000546
EpiControl
AF:
0.000119

ClinVar

ClinVar submissions as Germline

Significance:Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
5
not provided (5)
-
-
1
Gorlin syndrome;C1835820:Holoprosencephaly 7;C2751544:Basal cell carcinoma, susceptibility to, 1 (1)
-
-
1
not specified (2)
-
-
1
PTCH1-related disorder (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.068
BayesDel_addAF
Benign
-0.51
T
BayesDel_noAF
Benign
-0.49
CADD
Benign
8.4
DANN
Benign
0.93
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.3
FATHMM_MKL
Benign
0.050
N
LIST_S2
Benign
0.23
T
MetaRNN
Benign
0.0027
T
MetaSVM
Benign
-0.76
T
PhyloP100
-1.8
PROVEAN
Benign
-0.26
N
REVEL
Benign
0.22
Sift
Benign
0.81
T
Sift4G
Benign
0.21
T
Polyphen
0.0
B
Vest4
0.18
MVP
0.39
ClinPred
0.00089
T
GERP RS
-1.4
PromoterAI
0.054
Neutral
Mutation Taster
=95/5
polymorphism

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs202111971; hg19: chr9-98278972; COSMIC: COSV64594740; COSMIC: COSV64594740; API